Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SNDL vs CRON

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SNDL
SNDL Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$373M
5Y Perf.-83.1%
CRON
Cronos Group Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$1000M
5Y Perf.-59.9%

SNDL vs CRON — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SNDL logoSNDL
CRON logoCRON
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic
Market Cap$373M$1000M
Revenue (TTM)$937M$193M
Net Income (TTM)$-11M$-9M
Gross Margin27.2%32.5%
Operating Margin-0.8%-1.5%
Forward P/E34.9x
Total Debt$170M$2M
Cash & Equiv.$273M$792M

SNDL vs CRONLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SNDL
CRON
StockMay 20May 26Return
SNDL Inc. (SNDL)10016.9-83.1%
Cronos Group Inc. (CRON)10040.1-59.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: SNDL vs CRON

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CRON leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. SNDL Inc. is the stronger pick specifically for profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
SNDL
SNDL Inc.
The Quality Compounder

SNDL is the clearest fit if your priority is quality.

  • -1.2% margin vs CRON's -4.9%
Best for: quality
CRON
Cronos Group Inc.
The Income Pick

CRON carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.98
  • Rev growth 64.4%, EPS growth -100.0%, 3Y rev CAGR 30.6%
  • 14.9% 10Y total return vs SNDL's -98.3%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCRON logoCRON64.4% revenue growth vs SNDL's 2.8%
Quality / MarginsSNDL logoSNDL-1.2% margin vs CRON's -4.9%
Stability / SafetyCRON logoCRONBeta 0.98 vs SNDL's 1.18, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)CRON logoCRON+41.6% vs SNDL's +9.9%
Efficiency (ROA)CRON logoCRON-0.8% ROA vs SNDL's -0.8%, ROIC -0.8% vs -0.3%

SNDL vs CRON — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SNDLSNDL Inc.
FY 2022
Cannabis
100.0%$62M
CRONCronos Group Inc.
FY 2025
Cannabis Flower
74.0%$108M
Cannabis Extracts
25.7%$38M
Product and Service, Other
0.3%$411,000

SNDL vs CRON — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCRONLAGGINGSNDL

Income & Cash Flow (Last 12 Months)

SNDL leads this category, winning 4 of 6 comparable metrics.

SNDL is the larger business by revenue, generating $937M annually — 4.8x CRON's $193M. Profitability is closely matched — net margins range from -1.2% (SNDL) to -4.9% (CRON). On growth, CRON holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.
RevenueTrailing 12 months$937M$193M
EBITDAEarnings before interest/tax$49M-$810,000
Net IncomeAfter-tax profit-$11M-$9M
Free Cash FlowCash after capex$53M-$163,766
Gross MarginGross profit ÷ Revenue+27.2%+32.5%
Operating MarginEBIT ÷ Revenue-0.8%-1.5%
Net MarginNet income ÷ Revenue-1.2%-4.9%
FCF MarginFCF ÷ Revenue+5.6%-0.1%
Rev. Growth (YoY)Latest quarter vs prior year-4.4%+2.0%
EPS Growth (YoY)Latest quarter vs prior year+32.8%-100.0%
SNDL leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SNDL leads this category, winning 2 of 2 comparable metrics.
MetricSNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.
Market CapShares × price$373M$1000M
Enterprise ValueMkt cap + debt − cash$298M$209M
Trailing P/EPrice ÷ TTM EPS-32.61x
Forward P/EPrice ÷ next-FY EPS est.34.93x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.80x
Price / SalesMarket cap ÷ Revenue0.54x5.17x
Price / BookPrice ÷ Book value/share0.46x0.91x
Price / FCFMarket cap ÷ FCF8.73x
SNDL leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

CRON leads this category, winning 6 of 7 comparable metrics.

CRON delivers a -0.9% return on equity — every $100 of shareholder capital generates $-1 in annual profit, vs $-1 for SNDL. CRON carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNDL's 0.15x.

MetricSNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.
ROE (TTM)Return on equity-1.0%-0.9%
ROA (TTM)Return on assets-0.8%-0.8%
ROICReturn on invested capital-0.3%-0.8%
ROCEReturn on capital employed-0.4%-0.3%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.15x0.00x
Net DebtTotal debt minus cash-$102M-$790M
Cash & Equiv.Liquid assets$273M$792M
Total DebtShort + long-term debt$170M$2M
Interest CoverageEBIT ÷ Interest expense-1.16x
CRON leads this category, winning 6 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

CRON leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CRON five years ago would be worth $3,438 today (with dividends reinvested), compared to $2,020 for SNDL. Over the past 12 months, CRON leads with a +41.6% total return vs SNDL's +9.9%. The 3-year compound annual growth rate (CAGR) favors CRON at 9.6% vs SNDL's -5.9% — a key indicator of consistent wealth creation.

MetricSNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.
YTD ReturnYear-to-date-17.2%-3.0%
1-Year ReturnPast 12 months+9.9%+41.6%
3-Year ReturnCumulative with dividends-16.8%+31.7%
5-Year ReturnCumulative with dividends-79.8%-65.6%
10-Year ReturnCumulative with dividends-98.3%+1487.9%
CAGR (3Y)Annualised 3-year return-5.9%+9.6%
CRON leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CRON leads this category, winning 2 of 2 comparable metrics.

CRON is the less volatile stock with a 0.98 beta — it tends to amplify market swings less than SNDL's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRON currently trades 76.4% from its 52-week high vs SNDL's 49.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.
Beta (5Y)Sensitivity to S&P 5001.18x0.98x
52-Week HighHighest price in past year$2.89$3.43
52-Week LowLowest price in past year$1.15$1.83
% of 52W HighCurrent price vs 52-week peak+49.8%+76.4%
RSI (14)Momentum oscillator 0–10048.850.0
Avg Volume (50D)Average daily shares traded1.9M1.4M
CRON leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates SNDL as "Hold" and CRON as "Hold". Consensus price targets imply 174.3% upside for SNDL (target: $4) vs -12.2% for CRON (target: $2).

MetricSNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$3.95$2.30
# AnalystsCovering analysts615
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+3.0%+1.0%
Insufficient data to determine a leader in this category.
Key Takeaway

CRON leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). SNDL leads in 2 (Income & Cash Flow, Valuation Metrics).

Best OverallCronos Group Inc. (CRON)Leads 3 of 6 categories
Loading custom metrics...

SNDL vs CRON: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is SNDL or CRON a better buy right now?

For growth investors, Cronos Group Inc.

(CRON) is the stronger pick with 64. 4% revenue growth year-over-year, versus 2. 8% for SNDL Inc. (SNDL). Analysts rate SNDL Inc. (SNDL) a "Hold" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SNDL or CRON?

Over the past 5 years, Cronos Group Inc.

(CRON) delivered a total return of -65. 6%, compared to -79. 8% for SNDL Inc. (SNDL). Over 10 years, the gap is even starker: CRON returned +1488% versus SNDL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SNDL or CRON?

By beta (market sensitivity over 5 years), Cronos Group Inc.

(CRON) is the lower-risk stock at 0. 98β versus SNDL Inc. 's 1. 18β — meaning SNDL is approximately 20% more volatile than CRON relative to the S&P 500. On balance sheet safety, Cronos Group Inc. (CRON) carries a lower debt/equity ratio of 0% versus 15% for SNDL Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SNDL or CRON?

By revenue growth (latest reported year), Cronos Group Inc.

(CRON) is pulling ahead at 64. 4% versus 2. 8% for SNDL Inc. (SNDL). On earnings-per-share growth, the picture is similar: SNDL Inc. grew EPS 84. 1% year-over-year, compared to -100. 0% for Cronos Group Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SNDL or CRON?

SNDL Inc.

(SNDL) is the more profitable company, earning -1. 7% net margin versus -4. 9% for Cronos Group Inc. — meaning it keeps -1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNDL leads at -0. 5% versus -1. 5% for CRON. At the gross margin level — before operating expenses — CRON leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is SNDL or CRON more undervalued right now?

Analyst consensus price targets imply the most upside for SNDL: 174.

3% to $3. 95.

07

Which pays a better dividend — SNDL or CRON?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is SNDL or CRON better for a retirement portfolio?

For long-horizon retirement investors, Cronos Group Inc.

(CRON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1488% 10Y return). Both have compounded well over 10 years (CRON: +1488%, SNDL: -98. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between SNDL and CRON?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNDL is a small-cap quality compounder stock; CRON is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SNDL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

CRON

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 100%
  • Gross Margin > 19%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SNDL and CRON on the metrics below

Revenue Growth>
%
(SNDL: -4.4% · CRON: 201.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.